Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Citi
UBS
Farmers Insurance
AstraZeneca
US Department of Justice
Baxter
Cerilliant
McKinsey
Cantor Fitzgerald

Generated: December 12, 2018

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR DULOXETINE HYDROCHLORIDE

« Back to Dashboard

Clinical Trials for Duloxetine Hydrochloride

Trial ID Title Status Sponsor Phase Summary
NCT00036309 Duloxetine Versus Placebo in the Prevention of Relapse of Major Depressive Disorder Completed Eli Lilly and Company Phase 3 The purpose of this study is to determine if duloxetine is effective when compared to placebo in preventing recurrence of major depressive disorder in patients who have responded to open-label duloxetine treatment.
NCT00036335 Subject Information and Consent Form F1J-US-HMCB Duloxetine Once-Daily Dosing Versus Placebo in Patients With Major Depression and Pain Completed Eli Lilly and Company Phase 3 The purposes of this study are to determine whether an investigational drug can help patients suffering from major depression with pain symptoms, and gather data on the safety of the investigational drug including any side effects that might be associated with it.
NCT00042562 Open-Label Treatment With Duloxetine Hydrochloride Once-Daily Dosing for Evaluation of Stabilization Dose in Patients With Major Depression Completed Eli Lilly and Company Phase 3 The purposes of this study are to determine: The safety of duloxetine and any side effects that might be associated with it. Whether duloxetine can help patients with major depression. The safety associated with switching from a medication you may be taking for depression to taking duloxetine. It is possible that information collected during this study will be analyzed by the sponsor in the future to evaluate duloxetine for other possible uses or for other medical or scientific purposes other than those currently proposed.
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Duloxetine Hydrochloride

Condition Name

Condition Name for Duloxetine Hydrochloride
Intervention Trials
Major Depressive Disorder 51
Depression 28
Fibromyalgia 19
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Duloxetine Hydrochloride
Intervention Trials
Depression 104
Depressive Disorder 101
Depressive Disorder, Major 75
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Duloxetine Hydrochloride

Trials by Country

Trials by Country for Duloxetine Hydrochloride
Location Trials
United States 970
Canada 58
United Kingdom 31
Australia 30
France 29
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Duloxetine Hydrochloride
Location Trials
New York 53
California 51
Florida 50
Texas 46
Ohio 43
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Duloxetine Hydrochloride

Clinical Trial Phase

Clinical Trial Phase for Duloxetine Hydrochloride
Clinical Trial Phase Trials
Phase 4 88
Phase 3 88
Phase 2/Phase 3 7
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Duloxetine Hydrochloride
Clinical Trial Phase Trials
Completed 181
Recruiting 34
Unknown status 19
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Duloxetine Hydrochloride

Sponsor Name

Sponsor Name for Duloxetine Hydrochloride
Sponsor Trials
Eli Lilly and Company 127
Boehringer Ingelheim 38
Shionogi 10
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Duloxetine Hydrochloride
Sponsor Trials
Industry 217
Other 177
NIH 16
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Argus Health
Deloitte
Covington
Mallinckrodt
US Army
Daiichi Sankyo
Accenture
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.